Silence Therapeutics plc (SLN)
NASDAQ: SLN · IEX Real-Time Price · USD
21.61
-0.02 (-0.07%)
Apr 26, 2024, 4:30 PM EDT - Market closed
Silence Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for SLN stock have an average target of 57.25, with a low estimate of 42 and a high estimate of 75. The average target predicts an increase of 164.98% from the current stock price of 21.61.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SLN stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $45 | Buy | Maintains | $45 | +108.29% | Apr 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +247.14% | Mar 15, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $29 → $45 | Buy | Maintains | $29 → $45 | +108.29% | Mar 14, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 → $42 | Strong Buy | Maintains | $26 → $42 | +94.40% | Mar 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $75 | Strong Buy | Maintains | $75 | +247.14% | Mar 13, 2024 |
Financial Forecast
Revenue This Year
15.78M
from 25.38M
Decreased by -37.82%
Revenue Next Year
32.34M
from 15.78M
Increased by 104.98%
EPS This Year
n/a
EPS Next Year
n/a
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | 27.7M | 74.5M |
| Avg | 15.8M | 32.3M |
| Low | 1.0M | 10.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | 9.3% | 372.1% |
| Avg | -37.8% | 105.0% |
| Low | -96.0% | -34.9% |
EPS Forecast
| EPS |
|---|
| High |
| Avg |
| Low |
EPS Growth
| EPS Growth |
|---|
| High |
| Avg |
| Low |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.